-
Last quarter, its PBM revenues grew 32% as it processed 17% more mail choice and 26% more pharmacy network claims compared to the prior year period, benefiting from its leading market share in Medicare Part D prescription business as well as high growth in specialty pharmacy and strong adoption of its Maintenance Choice plans.
FORBES: Six Reasons Why We Are Bullish On CVS Caremark Stock
-
Finally, Louis Navellier , editor of Blue Chip Growth Letter, is still a big believer in consumer stocks, particularly specialty and discount retailers.
FORBES: Magazine Article
-
The company saw significant demand in the energy market during the quarter, leading to accelerated growth of its specialty additives.
FORBES: Valvoline Driving Ashland To New Highs